Analyst Price Targets — ALBO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 11, 2023 4:54 am | — | Cowen & Co. | $48.00 | $43.85 | Benzinga | Cowen & Co. Downgrades Albireo Pharma to Market Perform, Lowers Price Target to $48 |
| January 11, 2023 4:52 am | — | Jefferies | $42.00 | $43.85 | Benzinga | Jefferies Downgrades Albireo Pharma to Hold, Lowers Price Target to $42 |
| January 9, 2023 8:47 am | — | Wedbush | $42.00 | $43.95 | Benzinga | Wedbush Downgrades Albireo Pharma to Neutral, Lowers Price Target to $42 |
Latest News for ALBO
Albireo Energy Announces CEO Succession as Company Enters Next Stage of Accelerated Expansion
EDISON, N.J.--(BUSINESS WIRE)--Albireo Energy, a leading independent building controls and energy services provider and a Huron Capital portfolio company, today announced that Kevin Baxter has been appointed CEO, a leadership transition that reinforces the company's momentum and affirms Huron Capital's confidence in Albireo Energy's long-term strategy. Larry G. Wash, who has served as both co-Chairman and CEO, will…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALBO.
U.S. House Trading
No House trades found for ALBO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.